USA flag logo/image

An Official Website of the United States Government

BACTERIAL ENDOTOXINS AND OTHER MATERIALS OF MICROBIAL ORIGINHAVE BEEN PREPARED…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
4819
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
4819
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Ribi Immunochem Research, Inc.
553 OLD CORVALLIS RD Hamilton, MO 59840
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1986
Title: BACTERIAL ENDOTOXINS AND OTHER MATERIALS OF MICROBIAL ORIGINHAVE BEEN PREPARED IN NONTOXIC AND NONALLERGENIC FORMS THAT RETAIN THE CAPACITY TO MODIFY, IN A BENEFICIAL FASHION, CERTAIN BIOLOGICAL RESPONSES.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

BACTERIAL ENDOTOXINS AND OTHER MATERIALS OF MICROBIAL ORIGINHAVE BEEN PREPARED IN NONTOXIC AND NONALLERGENIC FORMS THAT RETAIN THE CAPACITY TO MODIFY, IN A BENEFICIAL FASHION, CERTAIN BIOLOGICAL RESPONSES. THE ULTIMATE OBJECTIVE OF THESE INVESTIGATIONS IS TO PROVIDE, IN A COST-EFFECTIVE MANNER, STANDARDIZED AND COMMERCIAL PREPARATIONS OF THESE MATERIALS THAT CAN USED FOR IMMUNOTHERAPY OF CANCER. TO THIS END, DURING PHASE I OF THE PROJECT, INITIAL PREPARATIONS OF DETOXIFIED ENDOTOXINS WILL BE SUPPLIED FOR ESTABLISHED ANTITUMOR SCREENS; NEW COMBINATIONS WILL BE PREPARED WITH THESE DETOXIFIED ENDOTOXINS AND OTHER BIO- LOGICAL RESPONSE MODIFIERS; MURINE MODELS OF LYMPHATIC, OVARIAN, SKIN, AND BLADDER CANCERS WILL BE ESTABLISHED FOR TESTING SUSCEPTIBILITY TO IMMUNOTHERAPY; AND FORMULATIONS OFTHE IMMUNOMODULATORS AS ADJUVANTS FOR USE WITH CANCER CELL ANTIGENS WILL BE INVESTIGATED. SUBSEQUENTLY, DURING PHASE II, VARIOUS FORMULATIONS OF THE IMMUNOTHERAPEUTICS WILL BE TESTED IN NCI SCREENS, IN THE INHOUSE TRANSPLANTABLE TUMOR MODELS, AND AS ADJUVANTS FOR VACCINES IN TWO SPONTANEOUS TUMOR SYSTEMS. ANY RESPONSE MODIFIERS THAT DEMONSTRATE POTENTIAL FOR ELICITING A THERAPEUTIC RESPONSE TO CANCERS WILL BECOME CANDIDATES FOR INCLUSION IN AN IND FOR CLINICAL TESTING IN HUMANS.

Principal Investigator:

John cantrell
PRINCIPAL INVESTIGATOR
4063636214

Business Contact:

Small Business Information at Submission:

Ribi Immunochem Research Inc
Po Box 1409 Ne 581 Old Corvallis Road Hamilton, MT 59840

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No